JP2010538252A5 - - Google Patents

Download PDF

Info

Publication number
JP2010538252A5
JP2010538252A5 JP2010522447A JP2010522447A JP2010538252A5 JP 2010538252 A5 JP2010538252 A5 JP 2010538252A5 JP 2010522447 A JP2010522447 A JP 2010522447A JP 2010522447 A JP2010522447 A JP 2010522447A JP 2010538252 A5 JP2010538252 A5 JP 2010538252A5
Authority
JP
Japan
Prior art keywords
sample
identification method
cypa
identifying
cyclophilin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010522447A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010538252A (ja
Filing date
Publication date
Priority claimed from GBGB0716804.0A external-priority patent/GB0716804D0/en
Application filed filed Critical
Publication of JP2010538252A publication Critical patent/JP2010538252A/ja
Publication of JP2010538252A5 publication Critical patent/JP2010538252A5/ja
Pending legal-status Critical Current

Links

JP2010522447A 2007-08-29 2008-08-29 器官損傷の同定方法 Pending JP2010538252A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0716804.0A GB0716804D0 (en) 2007-08-29 2007-08-29 Identifying organ damage
PCT/GB2008/002947 WO2009027703A2 (en) 2007-08-29 2008-08-29 Identifying organ damage

Publications (2)

Publication Number Publication Date
JP2010538252A JP2010538252A (ja) 2010-12-09
JP2010538252A5 true JP2010538252A5 (enExample) 2011-10-13

Family

ID=38616940

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010522447A Pending JP2010538252A (ja) 2007-08-29 2008-08-29 器官損傷の同定方法

Country Status (5)

Country Link
US (1) US8110371B2 (enExample)
EP (1) EP2183601A2 (enExample)
JP (1) JP2010538252A (enExample)
GB (1) GB0716804D0 (enExample)
WO (1) WO2009027703A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2730662A1 (en) 2008-11-12 2014-05-14 Caris Life Sciences Luxembourg Holdings Methods and systems of using exosomes for determining phenotypes
WO2011000874A1 (en) * 2009-07-01 2011-01-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting cardiovascular mortality risk
US9128101B2 (en) 2010-03-01 2015-09-08 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
BR112012025593A2 (pt) 2010-04-06 2019-06-25 Caris Life Sciences Luxembourg Holdings biomarcadores em circulação para doença
ITNA20110012A1 (it) * 2011-03-14 2012-09-15 Amal Raj Delfin Albert Procedura di isolamento e di purificazione degli esosomi urinari per la ricerca di biomarcatori proteici
CN105606811A (zh) * 2016-02-01 2016-05-25 中南大学 一种鼻咽癌诊断试剂盒
JP7444386B2 (ja) * 2018-06-07 2024-03-06 株式会社Lsiメディエンス ヒト尿からのマイクロベシクルの分離方法及び分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4436352A1 (de) * 1994-10-12 1996-04-18 Kay Brune Verfahren zur diagnostischen Beurteilung und Verlaufskontrolle sowie Arzneimittel zur Therapie von Schockzuständen beim Menschen
US6719969B1 (en) * 1999-08-09 2004-04-13 The Regents Of The University Of Michigan Treatment of liver disease and injury with CXC chemokines
WO2002054081A2 (en) * 2000-12-29 2002-07-11 Oxford Glycosciences (Uk) Limited Proteins, genes and their use for diagnosis and treatment of kidney response
US7469185B2 (en) * 2002-02-04 2008-12-23 Ocimum Biosolutions, Inc. Primary rat hepatocyte toxicity modeling
WO2007127848A1 (en) * 2006-04-26 2007-11-08 University Of Louisville Research Foundation, Inc Isolation of membrane vesicles from biological fluids and methods of using same

Similar Documents

Publication Publication Date Title
JP2010538252A5 (enExample)
Khreba et al. Kidney injury molecule 1 (KIM‐1) as an early predictor for acute kidney injury in post‐cardiopulmonary bypass (CPB) in open heart surgery patients
Hernández et al. Prostate‐specific antigen: a review of the validation of the most commonly used cancer biomarker
Chebib et al. Autosomal dominant polycystic kidney disease: core curriculum 2016
Ravegnini et al. Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis
Sathyanarayan et al. Elevated level of interleukin‐6 predicts organ failure and severe disease in patients with acute pancreatitis
Bureau et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease
Esmat et al. Role of Helicobacter pylori in patients with HCV‐related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progression
Stoot et al. The effect of a multimodal fast‐track programme on outcomes in laparoscopic liver surgery: a multicentre pilot study
Sikander et al. Association of serotonin transporter promoter polymorphism (5-HTTLPR) with microscopic colitis and ulcerative colitis
Lee et al. Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase
JP2013515270A5 (enExample)
Archimandritis et al. Rapid urease test is less sensitive than histology in diagnosing Helicobacter pylori infection in patients with non‐variceal upper gastrointestinal bleeding
Kim et al. Increased nuclear expression of nuclear factor kappa‐B p65 subunit in the eutopic endometrium and ovarian endometrioma of women with advanced stage endometriosis
Kasperska‐Zając et al. Acute phase inflammatory markers in patients with non‐steroidal anti‐inflammatory drugs (NSAIDs)‐induced acute urticaria/angioedema and after aspirin challenge
JP2007508527A5 (enExample)
Bosmans et al. Functional mucous layer and healing of proximal colonic anastomoses in an experimental model
Peoc’h et al. Biomarkers for acute mesenteric ischemia diagnosis: state of the art and perspectives
Seishima et al. Obesity was associated with a decreased postoperative recurrence of rectal cancer in a Japanese population
Feng et al. Novel urinary protein panels for the non‐invasive diagnosis of non‐alcoholic fatty liver disease and fibrosis stages
Schmid et al. The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: Which markers matter and how should they be used?
Cazzagon et al. Rise and fall of HCV‐related hepatocellular carcinoma in Italy: a long‐term survey from the ITA. LI. CA centres
Huang et al. Molecular characterization of a precision-cut rat liver slice model for the evaluation of antifibrotic compounds
To et al. The genetics of Barrett’s esophagus: a familial and population-based perspective
Ishiguro et al. Coexpression of aPKCλ/ι and IL‐6 in prostate cancer tissue correlates with biochemical recurrence